Skip to main content
Livermore
Livermore
ZHEN

Trexquant Investment LP

SEC CIK
0001633445
Latest filing
Aug 14, 2026

NRIX holding history

Nurix Therapeutics, Inc. in every 13F filed by Trexquant Investment LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NRIX overviewAll 13F holders of NRIXFull Q2 2026 holdings

Shares (Q2 2026)
17,645
Value
$428.1K
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of NRIX by Trexquant Investment LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202617,645$428.1K<0.1%−192,049−91.6%ReducedHolders
Q1 2026209,694$3.25M<0.1%+132,335+171.1%AddedHolders
Q4 202577,359$1.47M<0.1%+62,459+419.2%AddedHolders
Q3 202514,900$137.7K<0.1%−36,633−71.1%ReducedHolders
Q2 202551,533$587.0K<0.1%+51,533NewHolders
Q1 20250$00.0%−22,527−100.0%Sold outHolders
Q4 202422,527$424.4K<0.1%−136,734−85.9%ReducedHolders
Q3 2024159,261$3.58M<0.1%−79,321−33.2%ReducedHolders
Q2 2024238,582$4.98M0.1%+25,703+12.1%AddedHolders
Q1 2024212,879$3.13M0.1%+53,561+33.6%AddedHolders
Q4 2023159,318$1.64M<0.1%+71,252+80.9%AddedHolders
Q3 202388,066$692.2K<0.1%+32,212+57.7%AddedHolders
Q2 202355,854$558.0K<0.1%+21,107+60.7%AddedHolders
Q1 202334,747$308.6K<0.1%+7,697+28.5%AddedHolders
Q4 202227,050$297.0K<0.1%+2,064+8.3%AddedHolders
Q3 202224,986$326.0K<0.1%+14,636+141.4%AddedHolders
Q2 202210,350$131.0K<0.1%−33,978−76.7%ReducedHolders
Q1 202244,328$621.0K<0.1%+24,696+125.8%AddedHolders
Q4 202119,632$568.0K<0.1%+19,632NewHolders
Q2 20210$00.0%−12,337−100.0%Sold outHolders
Q1 202112,337$384.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.